VivoSeq
Other

Spinal Deformity

0

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Spinal Deformity is an early-stage landscape with 0 programs across 1 company. The most active players are Medtronic Spinal and Biologics.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

Medtronic Spinal and Biologics

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Recruiting3 · 75%
Completed1 · 25%

Clinical Trials

Trial Activity

Tranexamic Acid in Adult Spinal Deformity Surgery
Recruiting·HHospital for Special Surgery, New York·Phase 3·NCT03553186·100 enrolled
Tranexamic Acid Dosing in Adult Spinal Deformity Surgery
Completed·WWashington University School of Medicine·Phase 2/3·NCT02053363·64 enrolled
Feasibility of Wireless Continuous Vital Sign Monitoring and Impact on Patients Undergoing Adult Spinal Surgery in a General Ward
Recruiting·—·Preclinical·NCT07105189·150 enrolled
The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction
Recruiting·MMedtronic Spinal and Biologics·Preclinical·NCT05856370·1,000 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)